Epigenomics Enters Agreement With Biochain

News   Mar 31, 2016

 
Epigenomics Enters Agreement With Biochain
 
 
 

RELATED ARTICLES

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease Diagnosis

News

The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.

READ MORE

Cancer Pioneer Employs Physics to Approach Cancer

News

In the cover article of Oncotarget, February 20, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE